In the culmination of a 33-year quest, scientists are reporting a milestone in type 1 diabetes: the first time the disease has been markedly delayed in young people at high risk. According to Science Magazine, California researchers found that 2 weeks of an experimental intravenous drug held off disease by an average of about two years. The mainstay of type 1 diabetes treatment is insulin, discovered 97 years ago. Researcher Jeffrey Bluestone said, "On the one hand,” the outcome is “pretty exciting." But "on the other hand, now the real hard work begins.” That will mean considering how to move the treatment forward and determining whom it’s most likely to help.


More videos

RT 17 Jul 2019 13:30 CEST

Knife attacker shot in Spain

Wochit News 17 Jul 2019 13:17 CEST

Bitcoin Tumbles